GeneFerm Biotechnology Inkomsten in het verleden
Verleden criteriumcontroles 2/6
GeneFerm Biotechnology has been growing earnings at an average annual rate of 51.7%, while the Personal Products industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 19% per year. GeneFerm Biotechnology's return on equity is 4.1%, and it has net margins of 5.4%.
Belangrijke informatie
51.7%
Groei van de winst
51.1%
Groei van de winst per aandeel
| Personal Products Groei van de industrie | 13.9% |
| Inkomstengroei | 19.0% |
| Rendement op eigen vermogen | 4.1% |
| Nettomarge | 5.4% |
| Laatste winstupdate | 30 Jun 2024 |
Opbrengsten en kosten
Hoe GeneFerm Biotechnology geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 612 | 33 | 101 | 28 |
| 31 Mar 24 | 728 | 86 | 106 | 28 |
| 31 Dec 23 | 794 | 125 | 104 | 28 |
| 30 Sep 23 | 781 | 129 | 102 | 28 |
| 30 Jun 23 | 752 | 120 | 101 | 27 |
| 31 Mar 23 | 674 | 103 | 97 | 25 |
| 31 Dec 22 | 634 | 93 | 96 | 24 |
| 30 Sep 22 | 617 | 93 | 96 | 24 |
| 30 Jun 22 | 585 | 86 | 94 | 24 |
| 31 Mar 22 | 552 | 67 | 91 | 24 |
| 31 Dec 21 | 522 | 57 | 90 | 24 |
| 30 Sep 21 | 472 | 46 | 87 | 23 |
| 30 Jun 21 | 431 | 32 | 85 | 23 |
| 31 Mar 21 | 393 | 22 | 83 | 22 |
| 31 Dec 20 | 368 | 5 | 82 | 22 |
| 30 Sep 20 | 360 | -13 | 82 | 22 |
| 30 Jun 20 | 348 | -20 | 83 | 22 |
| 31 Mar 20 | 344 | -28 | 85 | 23 |
| 31 Dec 19 | 328 | -28 | 84 | 22 |
| 30 Sep 19 | 340 | -10 | 86 | 24 |
| 30 Jun 19 | 341 | -6 | 85 | 24 |
| 31 Mar 19 | 346 | 5 | 83 | 24 |
| 31 Dec 18 | 357 | 10 | 83 | 25 |
| 30 Sep 18 | 326 | 7 | 79 | 24 |
| 30 Jun 18 | 332 | 15 | 81 | 24 |
| 31 Mar 18 | 349 | 25 | 88 | 24 |
| 31 Dec 17 | 350 | 28 | 89 | 23 |
| 30 Sep 17 | 377 | 37 | 94 | 23 |
| 30 Jun 17 | 406 | 48 | 97 | 23 |
| 31 Mar 17 | 427 | 70 | 89 | 22 |
| 31 Dec 16 | 453 | 94 | 88 | 21 |
| 30 Sep 16 | 459 | 105 | 86 | 21 |
| 30 Jun 16 | 450 | 107 | 83 | 18 |
| 31 Mar 16 | 405 | 78 | 82 | 18 |
| 31 Dec 15 | 375 | 54 | 79 | 18 |
| 30 Sep 15 | 326 | 26 | 73 | 18 |
| 30 Jun 15 | 278 | -1 | 66 | 18 |
| 31 Mar 15 | 250 | -10 | 64 | 18 |
| 31 Dec 14 | 223 | -18 | 62 | 18 |
| 31 Dec 13 | 220 | 6 | 56 | 17 |
Kwaliteitswinsten: 1796 has high quality earnings.
Groeiende winstmarge: 1796's current net profit margins (5.4%) are lower than last year (16%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 1796 has become profitable over the past 5 years, growing earnings by 51.7% per year.
Versnelling van de groei: 1796's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: 1796 had negative earnings growth (-72.5%) over the past year, making it difficult to compare to the Personal Products industry average (-1%).
Rendement op eigen vermogen
Hoge ROE: 1796's Return on Equity (4.1%) is considered low.